Your browser doesn't support javascript.
loading
Mechanism of Fuzheng Kang'ai Formula Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer / 中国结合医学杂志
Chinese journal of integrative medicine ; (12): 425-433, 2022.
Artigo em Inglês | WPRIM | ID: wpr-928941
ABSTRACT
OBJECTIVE@#To study the mechanism of Chinese herbal medicine Fuzheng Kang'ai Formula (, FZKA) on tumor microenvironment (TME).@*METHODS@#CIBERSORTx was used for analysis of TME. Traditional Chinese Medicine Systems Pharmacology and Analysis Platform was applied to identify compounds-targets network and the Cancer Genome Atlas (TCGA) was employed to identify the differential expression genes (DEGs) between tumor and paracancerous tissues in lung adenocarcinoma (LUAD) from TCGA-LUAD. Additionally, DEGs with prognosis in LUAD was calculated by univariable and multivariate Cox regression. The core targets of FZKA were analyzed in lung adenocarcinoma TME. Protein-protein interaction database was employed to predict down-stream of target. Quantitative reverse transcription polymerase chain reaction was employed for biological experiment in A549, H1299 and PC9 cell lines.@*RESULTS@#The active and resting mast cells were significantly associated with prognosis of LUAD (P<0.05). Of the targets, CCNA2 as an important target of FZKA (hazard ratio=1.41, 95% confidential interval 1.01-2.01, P<0.05) was a prognostic target and significantly associated with mast cells. CCNA2 was positively correlated with mast cell activation and negatively correlated with mast cell resting state. BCL1L2, ACTL6A and ITGAV were down-stream of CCNA2, which were validated by qRT-PCR in A549 cell.@*CONCLUSION@#FZKA could directly bind to CCNA2 and inhibit tumor growth by regulating CCNA2 downstream genes and TME of NSCLC closely related to CCNA2.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Medicamentos de Ervas Chinesas / Proteínas Cromossômicas não Histona / Actinas / Carcinoma Pulmonar de Células não Pequenas / Proteínas de Ligação a DNA / Microambiente Tumoral / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humanos Idioma: Inglês Revista: Chinese journal of integrative medicine Ano de publicação: 2022 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Medicamentos de Ervas Chinesas / Proteínas Cromossômicas não Histona / Actinas / Carcinoma Pulmonar de Células não Pequenas / Proteínas de Ligação a DNA / Microambiente Tumoral / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humanos Idioma: Inglês Revista: Chinese journal of integrative medicine Ano de publicação: 2022 Tipo de documento: Artigo